Solid malignancy
Showing 1 - 25 of 8,658
Solid Malignancy, Lymphoma Trial in New York ([18F] 4-L-Fluoroglutamine (2S,4R))
Recruiting
- Solid Malignancy
- Lymphoma
- [18F] 4-L-Fluoroglutamine (2S,4R)
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 28, 2022
Cancer, Solid Tumor Trial in San Francisco (Personalized Synthetic Long Peptide Vaccine)
Enrolling by invitation
- Cancer
- Solid Tumor
- Personalized Synthetic Long Peptide Vaccine
-
San Francisco, CaliforniaQuest Clinical Research
Feb 20, 2023
Participants Previously Treated With Century Therapeutics
Not yet recruiting
- Hematological Malignancy
- Solid Tumor Malignancy
- No Intervention
- (no location specified)
Mar 3, 2023
Intracranial Metastatic Disease From Any Solid Malignancy Trial in Saint Louis (Ethos Therapy)
Completed
- Intracranial Metastatic Disease From Any Solid Malignancy
- Ethos Therapy
-
Saint Louis, MissouriWashington University School of Medicine
Nov 22, 2022
Solid Tumor Malignancy, Hematologic Malignancy, Leukemia Trial run by the NCI (mrna 1273 injection)
Recruiting
- Solid Tumor Malignancy
- +4 more
- mRNA-1273
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 14, 2023
Hematological Malignancy, Solid Tumor Trial (OT-A201, IMids, Bevacizumab)
Not yet recruiting
- Hematological Malignancy
- Solid Tumor
- OT-A201
- +4 more
- (no location specified)
Apr 24, 2023
Non-Hodgkin's Lymphoma, Myeloma, Active Solid Malignancy Trial in New York (PET Imaging using 124 IPUH71)
Active, not recruiting
- Non-Hodgkin's Lymphoma
- +2 more
- PET Imaging using 124 IPUH71
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 10, 2023
Immune Profiling for Cancer Immunotherapy Response
Recruiting
- Cancer
- +3 more
- Methylation Cytometry
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Nov 6, 2023
Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in Philadelphia, Greenville, San Antonio (AMG 820)
Completed
- Advanced Malignancy
- +5 more
- AMG 820
-
Philadelphia, Pennsylvania
- +2 more
Jan 18, 2023
Prospective Procurement of Tumor Tissue to Identify Novel
Enrolling by invitation
- Solid Tumors
- +7 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in
Active, not recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- Best Practice
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 8, 2022
Advanced Solid Tumor Malignancy Trial in Ghent (KBA1412, Pembrolizumab)
Recruiting
- Advanced Solid Tumor Malignancy
-
Ghent, BelgiumUniversity Hospital Ghent
Aug 11, 2022
Solid Tumor, Hematological Malignancy Trial in Fairfax (Locus Health iPhone App)
Not yet recruiting
- Solid Tumor
- Hematological Malignancy
- Locus Health iPhone App
-
Fairfax, VirginiaInova Schar Cancer Institute
Oct 24, 2023
Immunity to Infection in Healthy Participants and Cancer
Recruiting
- Influenza
- +3 more
- Biological sample collection
-
Tuebingen, Baden-Wuerttemberg, GermanyUniversity Hopsital Tuebingen
Mar 31, 2023
Advanced Malignant Solid Tumor, Metastatic Malignant Tumor in the Liver, Metastatic Malignant Tumor in the Lung Trial in Houston
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- +3 more
- Hafnium Oxide-containing Nanoparticles NBTXR3
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 2, 2022
Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in United States (AMG 337)
Completed
- Advanced Malignancy
- +5 more
- AMG 337
-
Los Angeles, California
- +7 more
Nov 3, 2022
Distress Associated With Coronavirus Disease 2019 and Telehealth
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +6 more
- Survey Administration
-
Houston, TexasM D Anderson Cancer Center
Sep 16, 2022
Solid Tumor, Hematological Malignancy Trial in Australia (ATG-017)
Recruiting
- Solid Tumor
- Hematological Malignancy
-
East Melbourne, Victoria, Australia
- +4 more
Jan 11, 2023
Solid Tumor, Unspecified, Adult, Haematological Malignancy Trial in Aalborg
Recruiting
- Solid Tumor, Unspecified, Adult
- Haematological Malignancy
-
Aalborg, DenmarkDepartment of Oncology, Aalborg University Hospital
Jan 20, 2023
Hematologic Malignancy, Solid Tumor, Fibrosis Trial in Seoul (Ivaltinostat, Placebo)
Not yet recruiting
- Hematologic Malignancy
- +2 more
- Ivaltinostat
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
Feb 6, 2023
Solid Tumor, Hematologic Malignancy Trial in Beijing (Eliglustat, Immune checkpoint inhibitor)
Recruiting
- Solid Tumor
- Hematologic Malignancy
- Eliglustat
- Immune checkpoint inhibitor
-
Beijing, ChinaDepartment of Biotherapeutic, Chinese PLA General Hospital
Apr 28, 2022
Molecular Services and EMR-Lab Integration Application for
Not yet recruiting
- Advanced Cancer
- +2 more
- Comprehensive Genomic Profile testing; ELIA software; Molecular Genetic Pathologist consultation
- limited genetic testing or no testing
-
Rock Hill, South CarolinaCarolina Blood and Cancer Care Associates
Oct 18, 2023
COVID-19 Vaccines in Cancer, Transplant or Cellular Therapy
Recruiting
- Cancer
- +7 more
-
Memphis, Tennessee
- +2 more
Mar 2, 2022